Conversations with Industry Leaders: Dr Sue Lim 1 April 2025

Conversations with Industry Leaders: Dr Sue Lim 1 April 2025

By Dr Stephanie Jones On 1st April I caught up with Dr Sue Lim in the latest in my series of “Conversations with Leaders in our Industry”. Dr Lim is an experienced former FDA director and licensed physician with around 2 decades of global drug development experience....
Understanding Gaucher Disease 

Understanding Gaucher Disease 

By Bethany Bridge     Gaucher disease is a rare genetic disorder caused by a mutation in the GBA1 gene and a subsequent deficiency in the enzyme glucocerebrosidase, which is responsible for breaking down the fat glucosylceramide into glucose and ceramide....
The MHRA’s Patient Involvement Strategy 2021-25

The MHRA’s Patient Involvement Strategy 2021-25

By Hannah Kerfoot Following the Cumberlege review, published in 2020, the MHRA launched their Patient Involvement Strategy 2021-25. Now, in its final year, Pharmora is taking a look at what has been accomplished and what is still to come.   What is the Patient...
Recent trends in the pharmaceutical industry: Patient-focus

Recent trends in the pharmaceutical industry: Patient-focus

By: Hannah Kerfoot  When attending conferences and conventions in the pharmaceutical industry in the past few years, you might have noticed, as we at Pharmora have, a shift in priorities. Patient-focus has been at the forefront in many industry discussions, and...